Skip to main content

Venture the Path Less TraveledTM

A healthcare venture capital firm rooted in the Midwest

Arboretum Ventures icon

Improving patient outcomes and access, reducing healthcare costs

Our progressive strategy of investing in under-ventured geographies and sectors, coupled with our expertise in building deep relationships with entrepreneurs, executives, and investment partners across the healthcare industry, are significant factors contributing to our success.

View our portfolio
medical devices icon
Medical Devices
life science tools icon
Life Science Tools
& Diagnostics
tech-enabled care delivery icon
Care Delivery
pharma adjacencies icon


We seek innovations that solve (big) healthcare problems and make a transformational impact from teams who are diverse in thought, geography, and demographics.


We have a proven formula for identifying early-stage startups that can create value in a capital-efficient manner, accelerate portfolio value, and deliver superior returns.

Portfolio Spotlight

We invest in today’s ideas to forge a path for better healthcare tomorrow

Where NeuMoDx started?
Molecular diagnostics is one of the fastest-growing segments within the in-vitro diagnostics market, but existing systems are expensive, complex, and lack sophisticated automation. Through a unique combination of automation and microfluidics, the NeuMoDx Molecular clinical PCR systems offer best-in-class ease of use, throughput, and cost per test.

Where NeuMoDx is today?
Arboretum collaborated with the team to set the strategic direction that helped accelerate the company’s product development timeline and helped recruit new investors. Since Arboretum’s investment, NeuMoDx gained regulatory approvals for its first assays, launched its product, and in September 2020, QIAGEN acquired NeuMoDx to strengthen its portfolio of automated molecular testing.

Ready to grow with us?
laboratory scientists
NewMoDX logo

We fuel the future of healthcare

under management across five funds
of the portfolio invested in under-ventured markets over 20 years
of all active companies have either a female / minority CEO or founder
patient - lives impacted
View portfolio

Shifting the venture capital paradigm

We are proud to be a Midwest venture capital firm operating with transparency, integrity, and approachability to help you realize your entrepreneurial and investor goals. Together, we’ll positively impact patients, communities, and healthcare.

Meet your team
Arboretum Ventures team


Tim Petersen brings a wealth of healthcare expertise and relationships to our company and is a very effective member of our Board of Directors. He rolls up his sleeves to assist us when it’s truly needed and has the good sense to stay out of the way when it’s not.

Lou SilvermanCEO Hicuity Health

As our Chairman, Paul McCreadie’s integrity, character, and talent creates a solid foundation of trust, which is essential for effective strategic thinking and decision making. I know that whether things are going well, or if we are facing challenges, I can always count on his collaborative, shoulder to shoulder support and entrepreneurial insight.

Mark ForchetteCEO Delphinus Medical Technologies

Jan Garfinkle has been a valued partner since the early formation of Strata. Her reputation in the business and deep network helped us attract an experienced syndicate of investors and has opened doors to strategic partners vital for our success.

Dan RhodesCEO Strata Oncology

Arboretum Ventures understands the importance of collaboration and passion in building a great company. Their expertise in clinical and reimbursement strategy along with a broad industry network were invaluable in fostering our success.

Surbhi SarnaCEO nVision Medical

Tom Shehab and the supporting Arboretum team provided not only the capital we needed, but also strategic advice, access to an extensive network of potential partners, and unceasing encouragement. Their support has brought out the best in our team and allowed us to focus on our vision of making neuromodulation therapies accessible and easier to use for millions of patients worldwide.

Jill SchiaparelliCEO Avation Medical

In the News

May 24, 2023 in Arboretum, Home Page, News Page

Jan Garfinkle Receives NVCA’s Venture Vanguard Award

In observance of its 50th anniversary, the National Venture Capital Association (NVCA) is pleased to formally launch its new Venture Vanguard Award, an initiative that recognizes exceptional individuals who have…
Read More
May 16, 2023 in Fifth Eye, News Page

Fifth Eye’s AHI System™ for Predictive Patient Analytics Now Available in Medical Informatics Corp.’s Sickbay™ Platform

Fifth Eye Inc., a provider of real-time clinical analytics, is pleased to announce that their Analytic for Hemodynamic Instability (AHI) is now available to customers using Medical Informatics Corp.’s Sickbay™…
Read More
May 16, 2023 in Akadeum, News Page

Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines

Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct…
Read More